Here are six key trends:
1. The market was valued at $31.5 billion in 2014.
2. It is expected to reach $53.6 billion in 2022.
3. It will grow at a compound annual growth rate of 6.8 percent.
4. Key factors driving the market include the increasing number of sports injury cases and the gaining popularity of western sports.
5. On the other hand, factors such as lack of trained professionals and cost of certain products are likely to stem the market growth.
6. Some key players in the market are Arthrex, Biomet, Stryker, DJO Global, Zimmer, Smith & Nephews and Xiros.
More articles on devices:
InVivo’s Q2 net loss hits $10.4M as spinal cord injury trial shows early success: 5 things to know
InVivo Therapeutics promotes 2 to bolster spinal cord injury innovation: 5 points
LDR revenue up 19.4%, net loss at $5.8M: 10 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
